ORF Biologics
Coralville, US · Founded 2024 · Iowa corporation
Founders & leadership
JK
Jay KamathExecutive
ST
Sara TernesExecutive
SH
Stephen HansonExecutive
AK
Anant KamathExecutive
NT
Nicholas TaiberNamed on SEC filing
RA
Roger A. BakerNamed on SEC filing
JR
John R. HuiskampNamed on SEC filing
Board
SM
Steven MichalicekBoard director
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 1 of 2 rounds · 2024–2026
▶$1.7MraisedJul 2026 · 17 investors · BiotechnologyRule 506(b)
▶$1.7MraisedJul 2026 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven MichalicekDirector
- Anant KamathExecutive Officer, Director
- Jay KamathExecutive Officer
- Sara TernesExecutive Officer
- Nicholas TaiberDirector
- Roger A. BakerDirector
- John R. HuiskampDirector
- Offering amount
- $2.5M
- Amount sold
- $1.7M
- First sale
- Jul 2026
- Incorporated
- Corporation, Iowa, 2024
- Federal exemptions
- 06b
▶$2.5MofferedDec 2024 · BiotechnologyRule 506(b)
▶$2.5MofferedDec 2024 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven MichalicekDirector
- Jay KamathExecutive Officer, Director
- Sara TernesExecutive Officer, Director
- Stephen HansonExecutive Officer, Director
- Anant KamathExecutive Officer, Director
- Offering amount
- $2.5M
- Minimum investment
- $50K
- Incorporated
- Corporation, Iowa, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has ORF Biologics raised?
- ORF Biologics has disclosed $1.7M raised across 1 of its 2 known rounds.
- Where is ORF Biologics headquartered?
- ORF Biologics is headquartered in Coralville, US.